KOSPIFood & Beverage006980

Woosung

₩18,040▼ 0.88%2026-11-18 close
Market Cap
₩55.7B
Turnover
₩16,684,790
Volume
908 shares
Shares out.
3.1M
PER
8.3×
PBR
0.2×
EPS
₩2,179
Dividend Yield
7.19%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩1,300 per share · Prices as of the 2026-11-18 close

01

Report overview

Feed-led earnings recovery, but quarterly profit swings

Woosung relies almost entirely on compound feed. Its operating profit rose sharply in 2025, but quarterly earnings swung between losses and profits through 2026.

  1. 1

    Compound feed accounted for 99.0% of consolidated revenue in the first three quarters of 2026, according to Vegannews.

  2. 2

    Operating profit reached KRW 19.4 billion in 2025, up 125.5% year on year, and the operating margin rose to 3.2%.

  3. 3

    After a KRW 3.3 billion attributable net loss in Q1 2026 and a KRW 3 billion loss in Q2, attributable net income returned to KRW 8.24 billion in Q3, while Q3 operating profit fell 32.8% year on year.

  4. 4

    Support for ASF-hit farms and products built on precision nutrition and low-methane feed form the core of the company's field strategy.

  5. 5

    The next checkpoints are whether 2026 sales reach the 1.08 million tonne target and the Q4 results in the 2026 annual report.

02

Business structure

Woosung manufactures and sells compound feed for livestock, aquaculture and pets. Vegannews reported that compound feed accounted for 99.0% of consolidated revenue in the first three quarters of 2026, and the company profile by Wisereport also puts the compound feed share in the 99% range.

By region, the Asan division holds the largest share of revenue, while Wisereport's Q1 2026 commentary cited weak results at the Gyeongsan division and an economic slowdown at overseas subsidiaries as pressure on profitability. Its customers are pig, poultry and Hanwoo farms served through a dealer network.

Chuksan News reported that Woosung Feed holds 1,648 tonnes, or 34%, of the 4,825 tonnes in the Seosan and Taean fattening market in South Chungcheong. Sales volume grew 1.5% in 2025 versus 2024, while national compound feed output fell about 1.3% in the same year, according to Chuksan News.

The company set a 2026 annual sales target of 1.08 million tonnes. Its product lineup includes the protein-plasma-free piglet feed Growth&Immune, launched on April 14, 2026, the precision-nutrition dairy feed Only Milk series, launched on April 27, 2026, and the certified low-methane Hanwoo feed Gamtan Hanwoo.

The company positions farm shipment results and technical support as its differentiators, citing cattle carcass weight up 51.9 kg after a partnership with a Chungnam Hanwoo cooperative. News1 reported on October 27, 2026 that the company would proceed with a merger with its distribution affiliate on October 29, 2026. That affiliate runs a pig-breeding integration business producing piglets from a farm with about 1,300 sows.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩162.3B₩5.7B3.5%
2025Q4₩163B₩5.7B3.5%
2026Q1₩148.6B₩1.2B0.8%
2026Q2₩164B₩300M0.2%
2026Q3₩177B₩3.8B2.2%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩612.3B-₩600M₩100M−0.1%0.1%132.0%
2023₩634.8B₩5.7B₩11.1B0.9%6.1%133.0%
2024₩606.2B₩8.6B₩19.7B1.4%9.8%115.1%
2025₩613B₩19.4B₩12.9B3.2%6.1%117.5%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-18

04

Earnings analysis

Annual revenue was KRW 612.3 billion in 2022, KRW 634.8 billion in 2023 (up 3.7% year on year), KRW 606.2 billion in 2024 (down 4.5%) and KRW 613 billion in 2025 (up 1.1%). Among 2022 to 2025, 2023 was the largest year and 2024 the smallest.

Operating profit moved from an operating loss of KRW 607 million in 2022 to operating profit of KRW 5.68 billion in 2023, a swing to profit from loss, then rose to KRW 8.59 billion in 2024 (up 51.2%) and KRW 19.4 billion in 2025 (up 125.5%), increasing for two consecutive years from 2024 through 2025.

Revenue stayed close to flat around the KRW 600 billion level over the same period, so the rise in operating margin from -0.1% in 2022 to 0.9%, 1.4% and 3.2% in 2025 reads as a profitability-driven change rather than one driven by sales expansion.

Attributable net income rose from KRW 126 million in 2022 to KRW 11.1 billion in 2023 (up 8,670.1%) and KRW 19.7 billion in 2024 (up 78.1%), then fell to KRW 12.9 billion in 2025 (down 34.3%). Among 2022 to 2025, 2024 was the largest year and 2022 the smallest.

In 2025 operating profit rose while attributable net income fell, so non-operating items likely played a role in the gap. Operating cash flow grew every year, from KRW 5.32 billion in 2022 to KRW 35.1 billion in 2025, and the debt ratio fell from 132.0% in 2022 to 117.5% in 2025 (115.1% in 2024).

Total equity at the end of 2025 was KRW 212.5 billion, and total liabilities were KRW 249.8 billion. On a quarterly basis, Q4 2025 revenue was KRW 163 billion (up 0.5% quarter on quarter) and operating profit was KRW 5.73 billion (up 0.9%), a steady stretch.

Q1 2026 revenue then fell to KRW 148.6 billion (down 8.9%), operating profit dropped to KRW 1.22 billion (down 78.6%), and the company posted an attributable net loss of KRW 3.3 billion.

Q2 2026 revenue recovered to KRW 164 billion (up 10.4%), but operating profit was only KRW 334 million (down 72.7%), with an attributable net loss of KRW 3 billion, a smaller loss than in Q1.

Q3 2026 revenue reached KRW 177 billion (up 7.9% quarter on quarter and 9.1% year on year), operating profit was KRW 3.82 billion (up 1,043.0% quarter on quarter but down 32.8% year on year), and attributable net income of KRW 8.24 billion (up 104.5% year on year) marked a return to profit.

Revenue rose for two consecutive quarters, from Q2 2026 through Q3 2026, after the Q1 2026 low, yet Q3 operating profit was below the year-earlier level, so top-line growth did not carry through to profit. Attributable net income for the last four quarters (Q4 2025 to Q3 2026) totaled KRW 5.61 billion.

05

Industry analysis

Compound feed demand moves with domestic livestock inventories and output. According to Chuksan News, national compound feed production fell about 1.3% in 2025, while Woosung's sales volume grew 1.5% in the same year, a modest gain share in a shrinking market.

The Hanwoo cattle industry is described as entering an upturn, although reports also point to a persistent gap between large and small producers.

In the pig sector, an IGR-I type ASF outbreak in early 2026 led to culling at nine customer farms with about 5,500 sows in breeding terms, and according to Chuksan News in August 2026, Woosung agreed to fund replacement gilts of up to 110% of the sows and feed costs until the first shipment.

On costs, livestock prices, disease and policy are cited as external variables for the compound feed industry, and rising cost volatility was named as a burden for the 2026 operating environment. Verified peer share comparisons are limited, so the company's differentiation is better described in qualitative terms.

The company emphasizes farm shipment results and technical support; in a partnership with a Chungnam Hanwoo cooperative, over 80% of members were reported to feed its Smart55 Hanwoo Maru series. Precision nutrition research and methane-reducing feed are also emerging as competitive areas for livestock feed suppliers.

06

Outlook

The nearest company target is a 2026 annual sales volume of 1.08 million tonnes, which Chuksan News reported as a goal built on 2025 volume growth. On the product side, the company signed an industry-academia agreement with Kangwon National University in January 2026 to develop precision nutrition techniques.

In March 2026 it signed an MOU with Hyundai Seosan Farm to co-develop a finishing feed based on self-sourced ingredients. In April 2026 it launched a protein-plasma-free piglet feed and a dairy feed series. A headline dated August 3, 2026 reported that the Vietnam subsidiary achieved a return to profit.

News1 reported that the merger with its distribution affiliate was scheduled for October 29, 2026, and that the combination is intended to link livestock operations from feed through processing.

However, Q3 2026 operating profit fell 32.8% year on year, so whether higher sales translate into a profit recovery depends on selling prices and the cost trend.

Q4 2026 results have not yet been filed in a periodic report, so whether the full-year 2026 operating margin exceeds the 3.2% recorded in 2025 is the next checkpoint. How the pig-breeding integration business from the merger is reflected in consolidated accounts is another item to check in the 2026 annual report.

07

Valuation

PER
8.3×
PBR
0.2×
ROE
2.7%
EPS
₩2,179
BPS
₩81,849
Dividend per share
₩1,300

The price-to-book ratio sits well below 1x, meaning the market values the company at a low multiple of its book equity, and market capitalization is also smaller than total equity.

The price-to-earnings multiple is calculated on attributable net income that fell 34.3% in 2025 and totaled KRW 5.61 billion over the last four quarters, so the multiple can move sharply whenever quarterly results change.

Dividend yield moves inversely to the share price, so the same payout carries a different yield depending on the price level.

Operating profit rose sharply in 2025, but according to Vegannews, cumulative operating profit for January to September 2026 fell 60.6% year on year, so the direction of earnings recovery has been mixed from quarter to quarter. Valuation should therefore be read alongside the annual earnings level confirmed in the 2026 annual report.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-18

08

Bull factors

Earnings base improved in 2025

Operating profit reached KRW 19.4 billion in 2025, up 125.5% year on year, and the operating margin climbed to 3.2% from -0.1% in 2022. Operating profit rose for two consecutive years from 2024 through 2025.

Operating cash flow also grew from KRW 5.32 billion in 2022 to KRW 35.1 billion in 2025, so both earnings and cash generation expanded in the filed figures.

Volume growth and product expansion

Sales volume grew 1.5% in 2025 versus 2024, while national compound feed output fell about 1.3% in the same year, according to Chuksan News. In 2026 the company launched a protein-plasma-free piglet feed and a dairy feed series, broadening its lineup by livestock type. Its 2026 annual sales target is 1.08 million tonnes.

Balance sheet trend improved

The debt ratio fell from 132.0% in 2022 to 117.5% in 2025, after 115.1% in 2024. Total equity at the end of 2025 was KRW 212.5 billion and total liabilities were KRW 249.8 billion. In Q3 2026, attributable net income returned to KRW 8.24 billion, moving quarterly earnings back into positive territory.

09

Bear factors

Quarterly earnings volatility

Attributable net losses of KRW 3.3 billion in Q1 2026 and KRW 3 billion in Q2 2026 marked two consecutive loss-making quarters. Q3 returned to profit, but operating profit of KRW 3.82 billion fell 32.8% year on year.

Revenue rose 9.1% over the same period, yet operating profit declined, which points to continued margin pressure.

Thin earnings base

Attributable net income over the last four quarters totaled KRW 5.61 billion, well below the KRW 12.9 billion recorded for 2025 as a full year. Attributable net income fell 34.3% in 2025. Even after operating profit recovered, the net income base remains vulnerable to quarter-to-quarter swings.

Livestock cycle and disease risk

National compound feed output fell about 1.3% in 2025. An IGR-I type ASF outbreak in early 2026 led to culling at nine farms with about 5,500 sows, and Woosung provided replacement and feed funding to affected farms. Rising cost volatility and a slowing economy were also cited as burdens on the operating environment.

10

Risk factors

Animal disease and biosecurity

Animal diseases such as ASF and foot-and-mouth disease directly affect feed demand. Chuksan News reported support for the nine customer farms culled in early 2026, and cooperative heads called for rapid compensation for foot-and-mouth-affected farms. Depending on how far disease spreads, herd sizes and feed orders at customer farms could decline together.

Raw material costs and livestock prices

Wisereport's company summary notes that the compound feed industry is sensitive to livestock prices, disease and policy. Rising cost volatility was cited as a burden in the 2026 operating environment. Q3 2026 revenue rose while operating profit fell, which may reflect cost pressure squeezing margins.

Regional and overseas exposure and merger integration

Wisereport cited weak results at the Gyeongsan division and an economic slowdown at overseas subsidiaries as pressure on profitability. Reports also indicated the Vietnam subsidiary returned to profit.

The merger with the distribution affiliate was reported as scheduled for October 29, 2026, and the earnings contribution of the pig-breeding integration business after the combination is a matter for the annual report.

11

What to watch next

  1. December 31, 2026

    Whether 2026 sales reach the 1.08 million tonne target, and whether volume growth exceeds the 1.5% recorded in 2025, which bears directly on the company's growth claims.

  2. March 31, 2027 (statutory filing deadline)

    Q4 2026 results, the full-year operating margin and attributable net income in the 2026 annual report. How the merger with the distribution affiliate is reflected in consolidated accounts is also checked in this report.

  3. May 15, 2027 (statutory filing deadline)

    The Q1 2027 quarterly report, which shows whether quarterly profits sustain the profitable pattern after the attributable net loss in Q1 2026.

12

Overall view

Woosung operates a single-line business in which compound feed accounts for 99% of revenue. Operating profit reached KRW 19.4 billion in 2025, up 125.5%, and the operating margin of 3.2% is higher than in 2022. The debt ratio fell to 117.5% in 2025 from 132.0% in 2022, and operating cash flow grew every year.

On the other side, attributable net losses in Q1 and Q2 2026 were followed by a return to profit in Q3, but Q3 operating profit fell 32.8% year on year, so revenue growth and profit have diverged. Attributable net income over the last four quarters totaled KRW 5.61 billion, so the earnings base remains thin.

In the industry, the decline in national compound feed output, disease risk such as ASF and cost volatility remain key variables.

Because positive and negative factors coexist, the next checkpoints are whether 2026 sales reach the 1.08 million tonne target and the Q4 results and operating margin in the 2026 annual report.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 18 more articles and sources
  1. vegannews.co.kr
  2. butler.works
  3. comp.fnguide.com
  4. comp.fnguide.com
  5. news.nate.com
  6. comp.wisereport.co.kr
  7. comp.wisereport.co.kr
  8. alphasquare.co.kr
  9. edaily.co.kr
  10. chukkyung.co.kr
  11. chuksannews.co.kr
  12. chuksannews.co.kr
  13. chuksannews.co.kr
  14. chuksannews.co.kr
  15. woosungfeed.co.kr
  16. pigpeople.net
  17. news1.kr
  18. chuksannews.co.kr

Report written 2026-11-18 · Data as of 2026-11-17

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis